The payment is to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law that prohibits the payment of kickbacks to generate federal healthcare business or induce patient referrals.
Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations
Wall Street Journal - 10 Oct 2024 23:19
The payment is to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law that prohibits the payment of kickbacks to generate federal healthcare business or induce patient referrals.
Share this Article
Recommended